New acne drug shows promise in clinical trial
NCT ID NCT04856917
First seen Sep 30, 2025 · Last updated May 16, 2026 · Updated 39 times
Summary
This study tested a new drug called imsidolimab for people with moderate to severe acne. 123 participants received either the drug or a placebo. The main goal was to see if the drug reduced the number of pimples and inflamed spots on the face after 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACNE VULGARIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site 10-101
San Antonio, Texas, 78213, United States
-
Site 10-102
College Station, Texas, 77845, United States
-
Site 10-103
Austin, Texas, 78759, United States
-
Site 10-104
Detroit, Michigan, 48202, United States
-
Site 10-105
Murfreesboro, Tennessee, 37130, United States
-
Site 10-106
Sherman Oaks, California, 91403, United States
-
Site 10-107
Tampa, Florida, 33613, United States
-
Site 10-108
Tampa, Florida, 33607, United States
-
Site 10-109
New Orleans, Louisiana, 70119, United States
-
Site 10-110
Portsmouth, New Hampshire, 03801, United States
-
Site 10-111
Fountain Valley, California, 92708, United States
-
Site 10-112
New Orleans, Louisiana, 70119, United States
-
Site 10-113
Sweetwater, Florida, 33172, United States
-
Site 10-114
Hot Springs, Arkansas, 71913, United States
-
Site 10-115
Waterloo, Ontario, N2J1C4, Canada
Conditions
Explore the condition pages connected to this study.